terguride
Sign in to saveAlso known as dironyl
Terguride (, ), sold under the brand name Teluron, is a serotonin receptor antagonist and dopamine receptor agonist of the ergoline family. It is approved for and used as a prolactin inhibitor in the treatment of hyperprolactinemia (high prolactin levels) in Japan. Terguride is taken by mouth.
Research
215 papers- Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats.The European respiratory journal · 2011
- Blocking properties of terguride at the 5-HT(2) receptor subtypes mediating cardiovascular responses in the rat.Canadian journal of physiology and pharmacology · 2020
- Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.The Journal of pharmacology and experimental therapeutics · 2012
- Terguride for dyskinesias.Neurology · 1993
- Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.Japanese journal of pharmacology · 1993
via PubMed
~3 min read
Encyclopedic overview
5 sectionsContents
- Pharmacology
- Pharmacodynamics
- Research
- See also
- References
Terguride (, ), sold under the brand name Teluron, is a serotonin receptor antagonist and dopamine receptor agonist of the ergoline family. It is approved for and used as a prolactin inhibitor in the treatment of hyperprolactinemia (high prolactin levels) in Japan. Terguride is taken by mouth.
==Pharmacology==
Excerpted from Wikipedia’s “terguride” article, available under the CC BY-SA 4.0 licence.
Available in 9 languages
via Wikidata sitelinks · CC0